As the coronavirus began pushing the nation into lockdown in March 2020, Joshua Coleman, an anti-vaccine campaigner who organizes anti-vaccine rallies, went on Facebook Live to give his followers a rallying speech. He laid out what he thought the pandemic really was: an opportunity.
“This is the one time in human history where every single human being across this country, possibly across the planet, but especially in this country, are all going to have an interest in vaccination and vaccines,” he said. “So it’s time for us to educate.”
Individuals vaccinated against COVID-19 with the Moderna option showcased higher antibody levels than those vaccinated with the Pfizer-BioNTech jab, according to results from a new study.
An intelligence community report released Friday was inconclusive as to whether COVID-19 originated in a lab or jumped from animals to humans naturally, though U.S. officials stated that it was not developed as a biological weapon.
One of the many hard lessons learned from Covid-19 has been that a robust and resilient domestic public health industrial base is essential to the health and security of the United States.
One year after becoming ill with the coronavirus, nearly half of patients in a large new study were still experiencing at least one lingering health symptom, adding to evidence that recovery from Covid-19 can be arduous and that the multifaceted condition known as “long Covid” can last for months.
The study, published Thursday in the journal The Lancet, is believed to be the largest to date in which patients were evaluated one year after being hospitalized for Covid. It involved 1,276 patients admitted to Jin Yin-tan Hospital in Wuhan, China, who were discharged between Jan. 7 and May 29, 2020.
Recent Comments